澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

DIMERIX LTD

0.500

+0.0102.04%

成交量：74.41萬

成交額：37.62萬

市值：3.00億

市盈率：-21.15

高：0.515

開：0.500

低：0.500

收：0.490

52周最高：0.785

52周最低：0.340

股本：6.00億

流通股本：4.68億

量比：0.79

換手率：0.16%

股息：- -

股息率：- -

每股收益(TTM):-0.024

每股收益(LYR):-0.024

淨資產收益率：-83.97%

總資產收益率：-32.13%

市淨率：22.44

市盈率(LYR):-21.15

資料載入中...

總覽公司新聞資訊公告

概念

新冠治療股+0.74%

醫藥生物股+0.52%

資金流向

資金流入：

資金流出：

新聞資訊

BUZZ-澳大利亞 Dimerix 公司以 48 億美元出售資產，創下 7 個月新高

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/DXB.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.5,"timestamp":1770613920000,"preClose":0.49,"halted":0,"volume":744093,"delay":0,"changeRate":0.02040816326530614,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.023645,"marketStatus":"未開盤","change":0.01,"latestTime":"02-09 16:12:00 AEDT","open":0.5,"high":0.515,"low":0.5,"amount":376209,"amplitude":0.030612,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.023645,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1770678000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.49,"openAndCloseTimeList":[[1770591600000,1770613200000]],"volumeRatio":0.788029422966157,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-32.13%","roe":"-83.97%","lyrEps":-0.023645,"volumeRatio":0.788029422966157,"shares":600396776,"dividePrice":0,"high":0.515,"amplitude":0.030612,"preClose":0.49,"low":0.5,"week52Low":0.34,"pbRate":"22.44","psRate":"53.73","week52High":0.785,"institutionHeld":0,"latestPrice":0.5,"eps":-0.023645,"divideRate":0,"volume":744093,"delay":0,"ttmEps":-0.023645,"open":0.5,"prevYearClose":0.55,"prevWeekClose":0.49,"prevMonthClose":0.505,"prevQuarterClose":0.55,"fiveDayClose":0.51,"twentyDayClose":0.54,"sixtyDayClose":0.495,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593103120","title":"BUZZ-澳大利亞 Dimerix 公司以 48 億美元出售資產，創下 7 個月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2593103120","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593103120?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 12:10","pubTimestamp":1766376617,"startTime":"0","endTime":"0","summary":"12月22日 - ** DimerixDXB.AX股价上涨12.5%至0.63澳元，创七个月来最高水平** 如果涨势得以保持，该股将创下六个月来的最大盘中涨幅** 生物技术公司称美国上市生物技术公司 BioMarin Pharmaceutical BMRN.O将以 48 亿美元收购  公司的美国商业许可合作伙伴 Amicus Therapeutics。** Amicus Therapeutics 是一家生物制药公司，负责向美国市场授权 DXB 的 DMX-200 药物，用于治疗罕见肾病。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nL4S3XS07W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","IE0002270589.USD","BMRN","LU2065169927.USD","BK4139","BK7501","BK7508","IE00B19Z3B42.SGD","LU2065171311.SGD","DXB.AU","IE00B7SZLL34.SGD","LU2065170008.USD","IE00B19Z3581.USD","LU2065171402.SGD","BK4566","FOLD"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DXB.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治療股","bkCode":"BK7501","id":"package_au_concept_xgzlg","changeRate":0.007439},{"market":"AU","name":"醫藥生物股","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.00521}]}}